Insurance
Jan. 4, 2024
McKinsey seeks OK of $78M settlement with insurers for opioid consulting
“We continue to believe that our past work was lawful and deny allegations to the contrary, and the settlement contains no admission of liability or wrongdoing,” McKinsey has said.
McKinsey & Co. Inc. and health insurers and benefits plans asked a federal judge for preliminary approval for a $78 million settlement to resolve claims the consultancy played a key role in the opioid epidemic.
“On behalf of lead counsel Elizabeth J. Cabraser [of Lieff Cabraser Heimann & Bernstein LLP] and myself as proposed class counsel, we are pleased to commence the settlement approval process for resolution of the third party ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In